Infectious Diseases

The Department of Infectious Diseases was established in 1969 and has a development history of nearly fifty years. It has developed into an institution for the diagnosis, treatment, and research of liver diseases and infectious diseases, integrating medical care, scientific research, teaching, and training. It is a key infectious diseases specialty designated by the Heilongjiang Provincial Health Commission and one of the key departments of the Fourth Affiliated Hospital of Harbin Medical University. It is an authorized site for awarding doctoral and master’s degrees in Infectious Diseases at Harbin Medical University and one of the first standardized training bases for specialist physicians approved by the National Ministry of Health. It is the initiating institution of the Heilongjiang Provincial Health Commission Alliance for the Prevention of Mother-to-Child Transmission of Blood-Borne Diseases.

The Department of Infectious Diseases has long been dedicated to clinical care and scientific research in liver diseases, various infectious diseases, fever of unknown origin, and other conditions. In 2013, it established the province’s first outpatient clinic for the prevention of mother-to-child transmission of hepatitis B and provided care in more than several thousand visits by pregnant women infected with hepatitis B virus, with a transmission-interruption success rate of 99.8%. It was one of the first institutions to join the National Hepatitis B Zero Mother-to-Child Transmission Project. It undertakes numerous research projects at the national, provincial, and municipal levels. It has received multiple provincial and municipal Science and Technology Progress Awards and multiple Provincial Medical New Technology Application Awards. It carries out multiple new medical technology projects, including: antiviral therapy after splenic embolization for chronic hepatitis C, the impact of dynamic changes in the alpha-fetoprotein isoform AFP-L3 before and after interventional treatment of liver cancer on antitumor efficacy and prognosis, plasma exchange combined with hemofiltration for the treatment of severe hepatitis, quantitative HBsAg testing to guide antiviral therapy for chronic hepatitis B, etc.

The Department of Infectious Diseases has established a liver disease research laboratory and possesses imported transient elastography equipment for measuring liver stiffness and fat content, as well as Real-time PCR instruments, CO2 cell culture incubators, and other advanced equipment capable of performing molecular biological testing and serological measurements for various liver diseases and multiple infectious diseases.